SCHEMBL16474341

SCHEMBL16474341

CCCCCc1ccc(Oc2ccc(C(=O)Oc3ccc4c5c(c(C(=O)OCC)cc4c3)C=CC(c3ccccc3)(c3ccc(N4CCCCC4)cc3)O5)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.34
CETP P11597 2/20 0.34
PTGS1 P23219 1/20 0.33
METAP1 P53582 1/20 0.33
SIRT1 Q96EB6 1/20 0.31
THRB P10828 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
AVPR2 P30518 1/20 0.31
OXTR P30559 1/20 0.31
AVPR1A P37288 1/20 0.31
S1PR1 P21453 1/20 0.31
STAT3 P40763 1/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HRH3 Q9Y5N1 1/20 0.30
BCL2 P10415 1/20 0.30
BCL2L1 Q07817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16474339 0.92 SIRT2 (0.37) SIRT2SIRT1SMN1; SMN2S1PR1MAPT
SCHEMBL16474345 0.92 SIRT2 (0.33) SIRT2METAP1SIRT1SMN1; SMN2MAPT
SCHEMBL16474355 0.89 LMNA (0.38) SIRT2METAP1SIRT1THRBSMN1; SMN2
SCHEMBL16474356 0.89 SIRT2 (0.32) SIRT2METAP1MEN1KMT2A
SCHEMBL13005275 0.88 SIRT2 (0.39) SIRT2SIRT1S1PR1MAPTGAA
SCHEMBL16479408 0.88 METAP1 (0.35) SIRT2METAP1SIRT1THRBSMN1; SMN2
SCHEMBL13005273 0.88 SIRT2 (0.38) SIRT2SIRT1S1PR1MAPTGAA
SCHEMBL13005280 0.86 SIRT2 (0.37) SIRT2THRBMAPTMEN1KMT2A
SCHEMBL16474349 0.86
SCHEMBL16474337 0.85 SIRT2 (0.36) SIRT2SIRT1S1PR1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES NR0B2, NR0B1, DHCR24 SIRT2 1036/4885CETP 4739/4885PTGS1 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.